Latest Breaking News On - Antonio breast cancer symposium - Page 8 : comparemela.com

Neoadjuvant Chemotherapy Could Help Patients With Breast Cancer Skip Regional Nodal Irradiation

No established standard of care currently exists after spread to the lymph nodes.

FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies

Trastuzumab deruxtecan and elacestrant represent important new treatment options.

Abemaciclib, NSAI Extend Overall Survival for Patients With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

The combination resulted in numerically longer OS compared with an NSAI alone.

HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer

Sara A. Hurvitz, MD, presents data from the phase 3 HER2CLIMB-02 study investigating tucatinib and trastuzumab emtansine in patients with previously treated HER2+ metastatic breast cancer.

Jaguar Health, Inc.: Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health's Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea